Profound Medical Corp
TSX:PRN
Profound Medical Corp
Cost of Revenue
Profound Medical Corp
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Profound Medical Corp
TSX:PRN
|
Cost of Revenue
-$2.8m
|
CAGR 3-Years
10%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Neovasc Inc
TSX:NVCN
|
Cost of Revenue
-$773.8k
|
CAGR 3-Years
-19%
|
CAGR 5-Years
26%
|
CAGR 10-Years
16%
|
|
Opsens Inc
TSX:OPS
|
Cost of Revenue
-CA$20.4m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-16%
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Cost of Revenue
-CA$13.7m
|
CAGR 3-Years
-81%
|
CAGR 5-Years
-38%
|
CAGR 10-Years
N/A
|
|
Theralase Technologies Inc
XTSX:TLT
|
Cost of Revenue
-CA$508.2k
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
MedMira Inc
XTSX:MIR
|
Cost of Revenue
-CA$156.8k
|
CAGR 3-Years
38%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
19%
|
See Also
What is Profound Medical Corp's Cost of Revenue?
Cost of Revenue
-2.8m
USD
Based on the financial report for Dec 31, 2023, Profound Medical Corp's Cost of Revenue amounts to -2.8m USD.
What is Profound Medical Corp's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-16%
Over the last year, the Cost of Revenue growth was 23%. The average annual Cost of Revenue growth rates for Profound Medical Corp have been 10% over the past three years , -16% over the past five years .